| Nephrotic Syndrome
Flexbumin 25% vs Albuked 25%
Side-by-side clinical, coverage, and cost comparison for nephrotic syndrome.Deep comparison between: Flexbumin vs Albuked with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsAlbuked has a higher rate of injection site reactions vs Flexbumin based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Albuked but not Flexbumin, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Flexbumin
Albuked
At A Glance
IV infusion
Human albumin / plasma volume expander
IV infusion
Plasma volume expander
Indications
- Hypoalbuminemia
- Respiratory Distress Syndrome, Adult
- Nephrotic Syndrome
- Erythroblastosis, Fetal
- Hypoproteinemia
- Respiratory Distress Syndrome, Adult
- Liver Failure, Acute
- Erythroblastosis, Fetal
- Peritonitis
- Pancreatitis
- Mediastinitis
- Cellulitis
- Nephrotic Syndrome
Dosing
Hypovolemic Shock Infants and young children: 2.5 to 5 mL per kg body weight IV; older children and adults: initial dose 100 to 200 mL IV, repeated after 15 to 30 minutes if response is inadequate. Do not exceed 1 mL/min in patients with normal blood volume.
Hypoalbuminemia Calculate body albumin compartment to be 80 to 100 mL per kg body weight; do not exceed a daily dose of 2 g of albumin per kg of body weight, administered IV.
Burns Dose determined by patient's condition and response to treatment after the first 24 hours, administered IV.
Erythroblastosis, Fetal 1 g per kilogram body weight IV prior to or during exchange transfusion.
Hypovolemic Shock Volume administered and speed of infusion adapted to the response of the individual patient; IV infusion.
Burns Beyond 24 hours post-injury, maintain plasma albumin ~2.5 +/- 0.5 g per 100 mL with plasma oncotic pressure of 20 mm Hg; IV infusion.
Hypoproteinemia 50-75 g daily (adults), 25 g daily (children); rate not exceeding 2 mL/min; IV infusion.
Contraindications
- History of hypersensitivity reaction to albumin preparations or to any excipient (N-acetyltryptophan and sodium caprylate)
- Severe anemia or cardiac failure with normal or increased intravascular volume
- History of congestive cardiac failure, renal insufficiency, or stabilized chronic anemia (risk of circulatory overload)
- History of allergic reaction to albumin
Adverse Reactions
Serious Hypersensitivity reaction, anaphylactic reaction, pulmonary edema
Postmarketing Anaphylactic shock, anaphylactic reaction, hypersensitivity/allergic reactions, headache, dysgeusia, myocardial infarction, atrial fibrillation, tachycardia, hypotension, flushing, pulmonary edema, dyspnea, vomiting, nausea, urticaria, rash, pruritus, pyrexia, chills
Allergic urticaria, chills, fever, changes in respiration, pulse, and blood pressure
From excessive administration high plasma protein levels
Pharmacology
Human albumin accounts for 70 to 80% of the colloid osmotic pressure of normal plasma and serves as a transport protein; administered as a 25% IV solution, it draws approximately 3.5 times its volume of additional fluid into the circulation within 15 minutes, expanding blood volume.
Albumin (Human) is a plasma protein that exerts oncotic (colloid osmotic) pressure, expanding plasma volume by drawing fluid from extravascular tissues; it also functions as a transport protein capable of binding substances such as bilirubin.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Flexbumin
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
Albuked
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
UnitedHealthcare
Flexbumin
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Albuked
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Flexbumin
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Albuked
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Flexbumin.
No savings programs available for Albuked.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
FlexbuminView full Flexbumin profile
AlbukedView full Albuked profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.